- Home
- WBX vs NTRB Comparison
WBX vs NTRB Comparison
Compare WBX & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- NTRB
- Stock Information
- Founded
- WBX 2015
- NTRB 2016
- Country
- WBX Spain
- NTRB United States
- Employees
- WBX N/A
- NTRB N/A
- Industry
- WBX Industrial Specialties
- NTRB Industrial Specialties
- Sector
- WBX Consumer Discretionary
- NTRB Health Care
- Exchange
- WBX Nasdaq
- NTRB Nasdaq
- Market Cap
- WBX 76.3M
- NTRB 71.8M
- IPO Year
- WBX N/A
- NTRB N/A
- Fundamental
- Price
- WBX $3.93
- NTRB $6.46
- Analyst Decision
- WBX Buy
- NTRB Buy
- Analyst Count
- WBX 4
- NTRB 1
- Target Price
- WBX $10.50
- NTRB $13.00
- AVG Volume (30 Days)
- WBX 19.9K
- NTRB 189.1K
- Earning Date
- WBX 07-31-2025
- NTRB 09-05-2025
- Dividend Yield
- WBX N/A
- NTRB N/A
- EPS Growth
- WBX N/A
- NTRB N/A
- EPS
- WBX N/A
- NTRB N/A
- Revenue
- WBX $173,788,608.00
- NTRB $2,398,437.00
- Revenue This Year
- WBX N/A
- NTRB $560.75
- Revenue Next Year
- WBX $46.25
- NTRB $588.39
- P/E Ratio
- WBX N/A
- NTRB N/A
- Revenue Growth
- WBX N/A
- NTRB 18.92
- 52 Week Low
- WBX $4.05
- NTRB $2.98
- 52 Week High
- WBX $30.00
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- WBX 43.33
- NTRB 42.89
- Support Level
- WBX $4.22
- NTRB $6.30
- Resistance Level
- WBX $4.50
- NTRB $6.66
- Average True Range (ATR)
- WBX 0.27
- NTRB 0.33
- MACD
- WBX -0.08
- NTRB 0.05
- Stochastic Oscillator
- WBX 4.85
- NTRB 54.84
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.